A new observational study finds patients in the hospital for COVID-19 have high levels of soluble urokinase receptor (suPAR), an immune-derived pathogenic protein that is strongly predictive of kidney injury.

A patient’s genetic makeup and journey with leukemia highlights the need for more gene sequencing in minority children.

A roundup of several recent Michigan Medicine discoveries that are shedding new light on pediatric brain cancers and helping to improve treatment options.

Researchers report first clinically actionable findings for a rare blood vessel disease in a study of four unrelated families, all with the same genetic variant.

Are the vaccine trials being rushed? Are they safe? Two Michigan Medicine researchers weigh in.

Conjoined twins attached at the chest and abdomen recently underwent successful separation surgery at Michigan Medicine C.S. Mott Children’s Hospital.

The disproportionate effect COVID-19 has had on Black Americans may worsen existing racial and ethnic disparities in cancer care, and make health equity harder to achieve.

Positive tests among dead could be early warning sign

When the COVID-19 pandemic first began, many non-urgent surgeries were delayed. Now, a new paper explains how to address the backlog of surgeries, without compromising patient outcomes.

A liver transplant recipient spends 40 days in the ICU at Michigan Medicine and recovers. He shares how his wife and a familiar doctor helped him survive.

For older adults, and others, de-intensifying medical treatment, screening or testing can bring benefits and reduce harms, but guidelines don’t often advise doctors.

Anxiety, depression, alcohol use and more have risen in 2020 thanks to COVID-19, social injustice and more. Experts offer tips for managing your mental health.

Loneliness and social isolation increased among older adults during the COVID-19 pandemic, but connections with neighbors and healthy habits helped.

A new study looks into the correlation between strong NIH research support and strong career development funding in ranked institutions.

U-M expert discusses whether repeat cases of COVID-19 is bad news for vaccines.